FI46259C - Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi. - Google Patents

Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.

Info

Publication number
FI46259C
FI46259C FI693710A FI371069A FI46259C FI 46259 C FI46259 C FI 46259C FI 693710 A FI693710 A FI 693710A FI 371069 A FI371069 A FI 371069A FI 46259 C FI46259 C FI 46259C
Authority
FI
Finland
Prior art keywords
benzodiazepin
alkyloxy
pyrrolo
hexahydro
ethylidene
Prior art date
Application number
FI693710A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI46259B (enrdf_load_stackoverflow
Inventor
Arima
Tamura
Sakai
Kohsaka
Kariyone
Yazawa
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44050780A external-priority patent/JPS4843755B1/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI46259B publication Critical patent/FI46259B/fi
Application granted granted Critical
Publication of FI46259C publication Critical patent/FI46259C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI693710A 1968-12-30 1969-12-22 Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi. FI46259C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8368 1968-12-30
JP44050780A JPS4843755B1 (enrdf_load_stackoverflow) 1969-06-26 1969-06-26

Publications (2)

Publication Number Publication Date
FI46259B FI46259B (enrdf_load_stackoverflow) 1972-10-31
FI46259C true FI46259C (fi) 1973-02-12

Family

ID=26332992

Family Applications (1)

Application Number Title Priority Date Filing Date
FI693710A FI46259C (fi) 1968-12-30 1969-12-22 Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.

Country Status (6)

Country Link
ES (1) ES375013A1 (enrdf_load_stackoverflow)
FI (1) FI46259C (enrdf_load_stackoverflow)
GB (1) GB1299198A (enrdf_load_stackoverflow)
IE (1) IE33906B1 (enrdf_load_stackoverflow)
IL (1) IL33558A (enrdf_load_stackoverflow)
RO (1) RO55813A (enrdf_load_stackoverflow)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464467A (en) * 1982-07-26 1984-08-07 Bristol-Myers Company Antitumor antibiotics produced by new streptomyces
AU757510C (en) * 1998-08-27 2003-09-11 Medimmune Limited Pyrrolobenzodiazepines
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
US6909006B1 (en) 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
GB0404577D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
ES2398975T3 (es) 2004-03-01 2013-03-25 Spirogen Sàrl Derivados de 11-hidroxi-5H-pirrolo[2,1-c][1,4]benzodiazepin-5-ona como intermedios clave para la preparación de pirrolobenzodiazepinas sustituidas en C2
JP5166861B2 (ja) 2004-03-09 2013-03-21 スピロゲン リミティッド ピロロベンゾジアゼピン
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
KR101671360B1 (ko) 2010-04-15 2016-11-01 시애틀 지네틱스, 인크. 표적화된 피롤로벤조디아제핀 접합체
SG11201400770SA (en) 2011-09-20 2014-04-28 Spirogen Sarl Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
ES2660233T3 (es) 2011-10-14 2018-03-21 Seattle Genetics, Inc. Pirrolobenzodiazepinas y conjugados dirigidos
CN103998449A (zh) 2011-10-14 2014-08-20 斯皮罗根有限公司 吡咯并苯并二氮杂卓
EP2755642B1 (en) 2011-10-14 2018-07-18 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
CN104011018B (zh) 2011-10-14 2016-12-14 麦迪穆有限责任公司 可用于制备吡咯并苯并二氮杂卓的合成方法和中间体
AU2012322934B2 (en) 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
SMT201900431T1 (it) 2012-10-12 2019-09-09 Medimmune Ltd Pirrolobenzodiazepine e loro coniugati
SI2906251T1 (en) 2012-10-12 2018-01-31 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
US10695433B2 (en) 2012-10-12 2020-06-30 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
HUE052835T2 (hu) 2012-10-12 2021-05-28 Medimmune Ltd Pirrolobenzodiazepinek és konjugátumaik
NZ707534A (en) 2012-10-12 2018-08-31 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
US10736903B2 (en) 2012-10-12 2020-08-11 Medimmune Limited Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
HRP20181646T2 (hr) 2012-10-12 2019-08-09 Adc Therapeutics Sa Konjugati pirolobenzodiazepin - anti-psma protutijela
CN105102068B (zh) 2012-10-12 2018-06-01 Adc疗法责任有限公司 吡咯并苯并二氮杂卓-抗体结合物
EP2906249B1 (en) 2012-10-12 2018-06-27 MedImmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP6878287B2 (ja) 2014-11-25 2021-05-26 アーデーセー セラピューティクス ソシエテ アノニム ピロロベンゾジアゼピン−抗体コンジュゲート
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
KR20200032243A (ko) 2017-02-08 2020-03-25 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
DK3612537T3 (da) 2017-04-18 2022-08-08 Medimmune Ltd Pyrrolobenzodiazepinkonjugater
US20200129637A1 (en) 2017-04-20 2020-04-30 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
KR102442736B1 (ko) 2017-06-14 2022-09-16 에이디씨 테라퓨틱스 에스에이 항-cd19 adc의 투여를 위한 투약량 체제
MX384245B (es) 2017-08-18 2025-03-14 Medimmune Ltd Conjugados de pirrolobenzodiazepina
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
KR20210139270A (ko) 2019-03-15 2021-11-22 메드임뮨 리미티드 암의 치료에 사용하기 위한 아제티도벤조디아제핀 이량체 및 이를 포함하는 컨쥬게이트

Also Published As

Publication number Publication date
IE33906B1 (en) 1974-12-11
IL33558A (en) 1973-10-25
GB1299198A (en) 1972-12-06
FI46259B (enrdf_load_stackoverflow) 1972-10-31
IE33906L (en) 1970-06-30
ES375013A1 (es) 1972-03-01
RO55813A (enrdf_load_stackoverflow) 1974-02-01
IL33558A0 (en) 1970-04-20

Similar Documents

Publication Publication Date Title
FI46259C (fi) Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.
FI51347C (fi) Menetelmä 1-substituoitujen-3- ja -4-aroyylipiperidiinien valmistamise ksi.
FI52574C (fi) Menetelmä farmakologisesti arvokkaiden substituoitujen N-allyyli-2-fen yyliamino-imidatsoliinien-(2) valmistamiseksi.
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
FI48588C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi.
DK123715B (da) Fremgangsmåde til fremstilling af 4'-demethylepipodophyllotoxin-β-D-alkylidenglucosider.
BG17560A3 (bg) Метод за получаане на 4,20, 22- буфатриеноли- драмнозид- етери
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
BG22815A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
DK127421B (da) Fremgangsmåde til fremstilling af cardenolid-3[2',3'-didesoxyglycosider].
BG19178A3 (bg) Метод за получаване на 8-субституирани-5н-пироло-(2,1-с) 1,4 бензодиазепин-5-они
FI44625C (fi) Menetelmä uusien terapeuttisesti arvokkaiden d-treo-1-fenyyli-2-amino-1,3-propaanidiolijohdannaisten valmistamiseksi
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
AR214033A1 (es) Procedimiento para preparar 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocinas
BE763173A (fr) Procede de preparation de 6-alcoxy-5,6-dihydro-4h-pyrannes
RO67383A (ro) Procedeu pentru prepararea unor 2,4-diamino-5-benzilpirimidine
FI46723C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI52225C (fi) Menetelmä terapeuttisesti käytettävien 15alfa,16alfa-metyleeni-4-estre eni-17beta-olien valmistamiseksi.
FI47181C (fi) Menetelmä tulehdusta estävien 2-kloori-6alfa,9alfa,11beta-trihalogeeni -16alfa-metyyli-pregnadieenin valmistamiseksi.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.
DK129041B (da) Analogifremgangsmåde til fremstilling af 6,21-dihalogen-3,16α,17α-trihydroxy-pregna-4,6-dien-20-oner.
BG15557A3 (bg) Метод за получаване на n-ацил-1,2-дикарбонил-фенил- хидразони